Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The Force of Mentorship: Self-improvement through Direction - 210 Setting up camp Shelters That Offer Both Excellence and Isolation
- 3Iran-backed militias reassert power in Iraq, proving the Islamic axis is still standing
- 4What will the Artemis 2 astronauts eat during their historic moon mission? (video)
- 5Pope Leo XIV calls for urgent climate action and says God’s creation is 'crying out'
- OpenAI launches ChatGPT Health to connect medical records, wellness apps
- 'Seditious behavior': Trump accuses Democrats who made video reminding the military not to follow illegal orders of a crime — but is it?
- 6 Top Computer game Control center
- Bayer sues COVID vaccine makers over mRNA technology
- 'We are ready': NASA still on track to launch Artemis 2 astronauts to the moon April 1
- 'Something Very Bad Is Going to Happen' is the Duffer Brothers' first project since 'Stranger Things.' It's also 'wildly insane.'
- 10 Famous Frozen yogurt Flavors All over The Planet
- Artemis II crew take new photo of far side of the moon
- Putin says Russian forces will seize capital of Zaporizhzhya
